References

1000 Genomes Project Consortium et al. A global reference for human genetic variation. Nature. 2015;526(7571):68.

Aragam KG, Jiang T, Goel A, et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nature Genetics. 2022;54(12):1803–15.

Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in mendelian randomization: Comparison of allele score and summarized data methods. Statistics in medicine. 2016;35(11):1880–906.

Foley CN, Staley JR, Breen PG, et al. A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits. Nature communications. 2021;12(1):764.

Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS genetics. 2014;10(5):e1004383.

GTEx Consortium. The GTEx consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369(6509):1318–30.

Hartiala JA, Han Y, Jia Q, et al. Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. European heart journal. 2021;42(9):919–33.

Kavousi M, Bos MM, Barnes HJ, et al. Multi-ancestry genome-wide analysis identifies effector genes and druggable pathways for coronary artery calcification. medRxiv. 2022;2022–05.

Mahajan A, Spracklen CN, Zhang W, et al. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nature genetics. 2022;54(5):560–72.

Malhotra R, Mauer AC, Lino Cardenas CL, et al. HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype. Nature genetics. 2019;51(11):1580–7.

Malik R, Chauhan G, Traylor M, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature genetics. 2018;50(4):524–37.

Malik R, Traylor M, Pulit SL, et al. Low-frequency and common genetic variation in ischemic stroke: The METASTROKE collaboration. Neurology. 2016;86(13):1217–26.

Mishra A, Malik R, Hachiya T, et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 2022;611(7934):115–23.

Morris JA, Kemp JP, Youlten SE, et al. An atlas of genetic influences on osteoporosis in humans and mice. Nature genetics. 2019;51(2):258–66.

Myers TA, Chanock SJ, Machiela MJ. LDlinkR: An r package for rapidly calculating linkage disequilibrium statistics in diverse populations. Frontiers in genetics. 2020;11:157.

Psaty BM, O’donnell CJ, Gudnason V, et al. Cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circulation: Cardiovascular Genetics. 2009;2(1):73–80.

Sudlow C, Gallacher J, Allen N, et al. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS medicine. 2015;12(3):e1001779.

Sun BB, Chiou J, Traylor M, et al. Plasma proteomic associations with genetics and health in the UK biobank. Nature. 2023;1–10.

Surakka I, Horikoshi M, Mägi R, et al. The impact of low-frequency and rare variants on lipid levels. Nature genetics. 2015;47(6):589–97.

Van Der Harst P, Verweij N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circulation research. 2018;122(3):433–43.

Wallace C. A more accurate method for colocalisation analysis allowing for multiple causal variants. PLoS genetics. 2021;17(9):e1009440.

Xue A, Wu Y, Zhu Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nature communications. 2018;9(1):2941.

Yang J, Ferreira T, Morris AP, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nature genetics. 2012;44(4):369–75.

Zheng J, Wheeler E, Pietzner M, et al. Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: Evidence from a genome-wide association meta-analysis followed by mendelian randomization. Arthritis & Rheumatology. 2023;75(10):1781–92.